Schonfeld Strategic Advisors

Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million

Retrieved on:

月曜日, 3月 18, 2024

Retina, GMS, Sale, Visium Asset Management, Bevacizumab, Schonfeld Strategic Advisors, Bank of America, Therapy, Security (finance)

ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses.

Key Points:

ISELIN, N.J., March 18, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the treatment of retinal diseases in the US and the EU, today announced that it has closed its previously announced private placement, for upfront gross proceeds of approximately $60 million from the issuance and sale of shares of the Company’s common stock and accompanying warrants, before deducting placement agent fees and offering expenses.
Outlook Therapeutics has the potential to receive additional gross proceeds of up to $99 million upon the full cash exercise of the warrants issued in the private placement, before deducting placement agent fees and offering expenses.
The private placement was led by Great Point Partners, LLC, with participation from existing investor GMS Ventures as well as new investors Altium Capital, Armistice Capital, Caligan Partners LP, Schonfeld Strategic Advisors, Sphera Healthcare, Velan Capital, Woodline Partners LP, and an undisclosed life sciences dedicated investor.
BofA Securities and BTIG acted as co-placement agents in connection with the financing.

Addepar Appoints Bob Pisani as Chief Technology Officer to Advance Data-Driven Investment Management

Retrieved on:

火曜日, 3月 5, 2024

Architecture, Engineering, Amazon Web Services, Private equity, AI, Growth, Schonfeld Strategic Advisors, Ecosystem, Amazon, College of Engineering (KNUST), Research, AWS, Cryptocurrency

NEW YORK, March 5, 2024 /PRNewswire/ -- Addepar, a global technology and data company trusted by the world's leading investment and advisory firms, announced today that Bob Pisani will serve as Chief Technology Officer, leading Addepar's global engineering teams to continue delivering ambitious, client-centric innovations. Pisani joined Addepar in 2020 to head Addepar's Platform Engineering, where he built and managed the teams driving Addepar's data, compute, and AI developments. Today this serves as the foundation for Addepar's global multi-product strategy.

Key Points:

NEW YORK, March 5, 2024 /PRNewswire/ -- Addepar , a global technology and data company trusted by the world's leading investment and advisory firms, announced today that Bob Pisani will serve as Chief Technology Officer, leading Addepar's global engineering teams to continue delivering ambitious, client-centric innovations.
Prior to joining Addepar, Pisani served as CTO at Schonfeld Strategic Advisors, a multi-billion dollar global hedge fund.
Pisani brings decades of deep hands-on engineering and financial services expertise to lead Addepar's world class technology teams.
He has guided the development of Addepar's platform, making outsized contributions to the company's growth and innovation," said Eric Poirier, Chief Executive Officer at Addepar.

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Retrieved on:

火曜日, 1月 23, 2024

Additionally, Outlook Therapeutics entered into securities purchase agreements with certain institutional and accredited investors for up to $172 million in gross proceeds to fund the advancement of ONS-5010.

Key Points:

Additionally, Outlook Therapeutics entered into securities purchase agreements with certain institutional and accredited investors for up to $172 million in gross proceeds to fund the advancement of ONS-5010.
Outlook Therapeutics expects NORSE EIGHT topline results and resubmission of the ONS-5010 BLA by the end of calendar year 2024.
Outlook Therapeutics is working to address the open items and expects to resolve these comments prior to the expected completion of NORSE EIGHT.
The private placement is expected to provide up to $60 million in gross proceeds at closing, before deducting placement agent fees and offering expenses.

Kiyatec strengthens its leadership position with the addition of Mark Capone, former CEO of Myriad Genetics, as Strategic Advisor

Retrieved on:

火曜日, 11月 21, 2023

View the full release here: https://www.businesswire.com/news/home/20231121720316/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20231121720316/en/
Kiyatec strengthens its leadership position with the addition of Mark Capone, former CEO of Myriad Genetics, as Strategic Advisor.
(Photo: Business Wire)
Mr. Capone is an accomplished life sciences CEO with almost 40 years of experience in molecular diagnostics, genetics, biotechnology, medical devices, and pharmaceuticals.
Kiyatec's innovative approach to personalized medicine and its commitment to improving patient outcomes are both inspiring and commendable,” said Mark Capone.
“Kiyatec is thrilled to have Mark Capone as a strategic advisor,” said Eric Perreault, President of Kiyatec.

HealthBook+ Appoints Former U.S. Senator, Leaders in Business, as Strategic Advisors

Retrieved on:

火曜日, 12月 5, 2023

Crypto, Policy, Organization, Risk management, Medicine, Chairperson, Pharmacy, Schonfeld Strategic Advisors, Social, Growth, Hospital, AI, Innovation, Telehealth, Legislation, Public, Medical device, Management

DENVER, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Advisors will provide guidance on corporate development, fundraising and navigating evolving regulations in digital health, AI and information privacy.

Key Points:

"I am truly humbled that these exemplary leaders have chosen to devote their time and intellect to helping HealthBook+ accelerate its future growth," said HealthBook+ CEO Christopher Turner.
HealthBook+, the digital-first, AI-powered health facilitation platform that allows individuals to understand their Next Best Heath Action™, today announced the appointment of four world class individuals as Strategic Advisors to the company.
The initial group of Strategic Advisors are:
Cory Gardner – a former U.S.
The company also recently added features focused on the needs of concierge and direct primary care practices .

Volante Technologies enhances Volante Experience to support the digital transformation needs of financial institutions

Retrieved on:

水曜日, 11月 22, 2023

Gupta, Command center, Software, Payments as a service, Insurance, Schonfeld Strategic Advisors, Ecosystem, EVP, Automation, Volante, Software as a service, Platform as a service, Mobile phone, Online shopping, Retail, Cryptocurrency, Engineering

NEW YORK, Nov. 22, 2023 /PRNewswire/ -- Volante Technologies, the global leader in cloud payments modernization, today announced the general availability of the latest version of the Volante Experience™.

Key Points:

Following the initial launch of the Volante Experience , which focused on the onboarding experience, this latest release enhances Volante's Payments as a Service (PaaS) to support financial institutions on their digital transformation journey and speed up innovation.
Banks that deploy Volante Experience will gain a 360-degree view of their customers and support the growing demands of payments modernization and digital transformation initiatives.
"This latest release of the Volante Experience represents a pivotal moment for the financial services industry," said Deepak Gupta, EVP of Product, Engineering and Service, Volante Technologies.
Delve deeper here to find out how Volante Experience is supporting the digital transformation needs of financial institutions and helping them innovate at the speed of business.

My Crew Doses Inc. Announces the No Fallen Heroes Partnership and Addition of Key Strategic Investors and Advisors

Retrieved on:

木曜日, 11月 9, 2023

"We've assembled an exceptional dream team composed of highly motivated leaders who are currently excelling in their careers.

Key Points:

"We've assembled an exceptional dream team composed of highly motivated leaders who are currently excelling in their careers.
Strategic Advisors and Veteran Support:
Included on our advisory team is AJA Partners, led by Andrea McLenon, Angie Weber, and Jon Weber.
A portion of all sales will be donated to the No Fallen Heroes Foundation, a 501c3 non-profit founded by Buckley.
"The No Fallen Heroes Foundation provides healing grants to Veterans, First Responders, and their families who seek to heal with psychedelic-assisted therapy.

MacKay CEO Forums, a Leading Canadian CEO and Executive Peer Learning Network, Announces New Ownership Structure That Positions It for Continued Technology-Enabled Growth

Retrieved on:

木曜日, 11月 2, 2023

MCF, Life, Schonfeld Strategic Advisors, Peer group, Doctor of Philosophy, Platinum Partners, Backcheck, Learning, Growth, Partnership, CFO, Mackay, Management

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2023) - MacKay CEO Forums ("MCF"), a leading Canadian network for CEO and Executive Peer Learning, has announced a change in its ownership structure.

Key Points:

Vancouver, British Columbia--(Newsfile Corp. - November 2, 2023) - MacKay CEO Forums ("MCF"), a leading Canadian network for CEO and Executive Peer Learning, has announced a change in its ownership structure.
"I'm very excited to once again be the majority owner of our company," said Nancy MacKay.
We are very pleased about the resulting agreement and look forward to strategically investing in our brand and accelerating growth under this new structure.
Mike Cordoba, Founder, Empresario Capital said, "As a long-time member of MacKay, I can attest to the power of peer learning firsthand.

Hammerhead Energy Inc. Enters into Agreement to be Acquired by Crescent Point Energy Corp.

Retrieved on:

月曜日, 11月 6, 2023

CALGARY, Alberta, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Hammerhead Energy Inc. ("Hammerhead") (TSX: HHRS ; NASDAQ: HHRS) is pleased to announce that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") with Crescent Point Energy Corp. (“Crescent Point”) (TSX: CPG ; NYSE: CPG) pursuant to which Crescent Point has agreed to acquire all of the issued and outstanding Class A common shares of Hammerhead ("Hammerhead Shares") for total consideration of C$21.00 per Hammerhead Share (the "Purchase Price").

Key Points:

CALGARY, Alberta, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Hammerhead Energy Inc. ("Hammerhead") (TSX: HHRS ; NASDAQ: HHRS) is pleased to announce that it has entered into a definitive arrangement agreement (the "Arrangement Agreement") with Crescent Point Energy Corp. (“Crescent Point”) (TSX: CPG ; NYSE: CPG) pursuant to which Crescent Point has agreed to acquire all of the issued and outstanding Class A common shares of Hammerhead ("Hammerhead Shares") for total consideration of C$21.00 per Hammerhead Share (the "Purchase Price").
The delivery of superior operational and financial results for all shareholders is a testament to our management team partners and all Hammerhead employees.”
Attractive Value for Hammerhead Shareholders.
Hammerhead has also granted Crescent Point a right-to-match any superior proposal and will pay a termination fee of C$85 million to Crescent Point if the Arrangement Agreement is terminated in certain circumstances.
Crescent Point has also agreed to pay a termination fee of C$85 million to Hammerhead if the Arrangement Agreement is terminated in certain circumstances.

BlueFlame Assembles Strategic Advisors to Advance Generative AI Initiatives for the Alternative Investment Industry

Retrieved on:

月曜日, 10月 30, 2023

Finance, Security, Professional Services, Technology, Artificial Intelligence, Former, Schonfeld Strategic Advisors, Fintech, LLM Communications, Growth, Safety, Blackstone, Capital, Customer service, Financial adviser, Consultant, AI

BlueFlame AI , the generative AI platform for alternative investment managers, today announced its panel of Strategic Advisors .

Key Points:

BlueFlame AI , the generative AI platform for alternative investment managers, today announced its panel of Strategic Advisors .
Comprised of industry luminaries with decades of experience in the alternatives space, the group will help drive BlueFlame’s expansion strategy and product roadmap as it brings tailored generative AI experiences to the industry to help firms capture significant time savings and efficiency gains.
BlueFlame’s Strategic Advisors include existing clients, investment professionals, and esteemed FinTech operators with deep industry expertise across investment management, technology, cybersecurity and compliance.
The group will support BlueFlame as it advances its client-driven product strategy and global growth initiatives to transform how firms harness the power of AI and Large Language Models (LLMs), with safety and compliance at the forefront.